AI Article Synopsis

  • - The study focuses on the FXIII-B subunit, known for stabilizing FXIII-A, and investigates the unclear function of excess free FXIII-B in plasma, particularly its interactions with complement factors.
  • - Researchers tested whether FXIII-B could act as a cofactor for complement degradation and used various assays to explore its binding partners, finding no significant interaction with complement components.
  • - While FXIII-B didn’t show regulatory activity in the complement system, α-macroglobulin (α2MG) was identified as a potential binding partner, necessitating further investigations to understand this relationship.

Article Abstract

Background: The factor XIII (FXIII)-B subunit has a critical function as a carrier protein to stabilize FXIII-A in plasma and supply it to its main substrate, fibrinogen. However, the function of the excess free FXIII-B circulating in plasma is still elusive.

Objectives: In the present study, we explored potential interactions of free FXIII-B with complement factors and searched for novel binding partners.

Methods: We tested for cofactor activity in the degradation of complement C3b and C4b and used ELISA- and surface plasmon resonance-based binding assays to investigate interactions between FXIII-B and complement components. We performed immunoprecipitation and mass spectrometry analysis to identify potential binding partners of free FXIII-B in freshly drawn plasma samples.

Results: FXIII-B did not exhibit cofactor activity in the degradation of C3b and C4b similar to factor H and C4b-binding protein, nor did it bind to complement factors to a relevant extent. Identification of proteins potentially binding to free FXIII-B revealed high interindividual variation. We confirmed α-macroglobulin (α2MG) as a candidate, although direct interactions or functional effects remain to be validated.

Conclusions: Our study reveals that free FXIII-B has no direct role in regulating the complement system, despite a structural similarity to major complement regulators. Further studies are needed to validate α2MG as a binding partner and explore potential functional consequences of this binding.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301527PMC
http://dx.doi.org/10.1002/rth2.12766DOI Listing

Publication Analysis

Top Keywords

free fxiii-b
20
complement factors
12
factor xiii
8
identify potential
8
potential binding
8
binding partners
8
fxiii-b
8
fxiii-b complement
8
cofactor activity
8
activity degradation
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!